Detalhe da pesquisa
1.
C reactive protein utilisation, a biomarker for early COVID-19 treatment, improves lenzilumab efficacy: results from the randomised phase 3 'LIVE-AIR' trial.
Thorax
; 78(6): 606-616, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35793833
2.
GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts.
Blood
; 133(7): 697-709, 2019 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30463995
3.
Clinical and economic benefits of lenzilumab plus standard of care compared with standard of care alone for the treatment of hospitalized patients with COVID-19 in the United States from the hospital perspective.
J Med Econ
; 25(1): 160-171, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35037816
4.
Clinical and Economic Benefits of Lenzilumab Plus Standard of Care Compared with Standard of Care Alone for the Treatment of Hospitalized Patients with Coronavirus Disease 19 (COVID-19) from the Perspective of National Health Service England.
Clinicoecon Outcomes Res
; 14: 231-247, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35444434
5.
Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial.
Lancet Respir Med
; 10(3): 237-246, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34863332
6.
GM-CSF disruption in CART cells modulates T cell activation and enhances CART cell anti-tumor activity.
Leukemia
; 36(6): 1635-1645, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35440691
7.
LENZILUMAB EFFICACY AND SAFETY IN NEWLY HOSPITALIZED COVID-19 SUBJECTS: RESULTS FROM THE LIVE-AIR PHASE 3 RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL.
medRxiv
; 2021 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33972949
8.
GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia: A Case-Cohort Study.
Mayo Clin Proc
; 95(11): 2382-2394, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33153629
9.
First Clinical Use of Lenzilumab to Neutralize GM-CSF in Patients with Severe COVID-19 Pneumonia.
medRxiv
; 2020 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32587983